Skip to Content

User Reviews for Aldesleukin

Also known as: Proleukin

Aldesleukin has an average rating of 10.0 out of 10 from a total of 1 ratings on Drugs.com. 100% of those users who reviewed Aldesleukin reported a positive effect, while 0% reported a negative effect.

Condition Avg. Rating Reviews Compare
Renal Cell Carcinoma 10.0
1 reviews 16 medications
Summary of Aldesleukin reviews 10.0 1 reviews

Reviews may be moderated or edited before publication to correct grammar and spelling or to remove inappropriate language and content. Reviews that appear to be created by parties with a vested interest in the medication will not be published. As reviews and ratings are subjective and self-reported, this information should not be used as the basis for any statistical analysis or scientific studies.

RGTucker September 13, 2010

Proleukin (aldesleukin) for Renal Cell Carcinoma: “I was diagnosed with Stage IV Renal Cell Carcinoma (RCC) in April 2009, and told by my primary care physician that my prognosis was approximately 6-9 months, perhaps a year. I found an oncologist that specialized in RCC and was told that this was the only course of action that had the potential to cure, not just stall the progression of my cancer. After 3 courses, I have had a complete response - no detectable cancer for 6 months so far.”

10 / 10

This information is NOT intended to endorse any particular medication. While these reviews might be helpful, they are not a substitute for the expertise, knowledge and judgement of healthcare practitioners.